Vicarious Surgical (RBOT) Competitors $5.46 -0.48 (-8.00%) Closing price 03:59 PM EasternExtended Trading$5.58 +0.11 (+2.01%) As of 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RBOT vs. SPAI, PROF, INO, HYPR, PDEX, NSPR, BDMD, OBIO, FONR, and EDAPShould you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Safe Pro Group (SPAI), Profound Medical (PROF), Inovio Pharmaceuticals (INO), Hyperfine (HYPR), Pro-Dex (PDEX), InspireMD (NSPR), Baird Medical Investment (BDMD), Orchestra BioMed (OBIO), Fonar (FONR), and Edap Tms (EDAP). These companies are all part of the "medical equipment" industry. Vicarious Surgical vs. Its Competitors Safe Pro Group Profound Medical Inovio Pharmaceuticals Hyperfine Pro-Dex InspireMD Baird Medical Investment Orchestra BioMed Fonar Edap Tms Safe Pro Group (NASDAQ:SPAI) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership. Do insiders & institutionals have more ownership in SPAI or RBOT? 47.3% of Vicarious Surgical shares are owned by institutional investors. 54.8% of Safe Pro Group shares are owned by insiders. Comparatively, 12.0% of Vicarious Surgical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better earnings & valuation, SPAI or RBOT? Safe Pro Group has higher revenue and earnings than Vicarious Surgical. Safe Pro Group is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSafe Pro Group$2.17M59.29-$7.43M-$0.80-8.55Vicarious SurgicalN/AN/A-$63.22M-$10.09-0.54 Do analysts rate SPAI or RBOT? Safe Pro Group currently has a consensus price target of $10.50, indicating a potential upside of 53.51%. Vicarious Surgical has a consensus price target of $7.00, indicating a potential upside of 28.09%. Given Safe Pro Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe Safe Pro Group is more favorable than Vicarious Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Safe Pro Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67Vicarious Surgical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is SPAI or RBOT more profitable? Vicarious Surgical has a net margin of 0.00% compared to Safe Pro Group's net margin of -731.46%. Vicarious Surgical's return on equity of -148.14% beat Safe Pro Group's return on equity.Company Net Margins Return on Equity Return on Assets Safe Pro Group-731.46% -328.85% -248.09% Vicarious Surgical N/A -148.14%-98.07% Does the media favor SPAI or RBOT? In the previous week, Safe Pro Group had 3 more articles in the media than Vicarious Surgical. MarketBeat recorded 5 mentions for Safe Pro Group and 2 mentions for Vicarious Surgical. Safe Pro Group's average media sentiment score of 1.49 beat Vicarious Surgical's score of 0.00 indicating that Safe Pro Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Safe Pro Group 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vicarious Surgical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummarySafe Pro Group beats Vicarious Surgical on 10 of the 15 factors compared between the two stocks. Get Vicarious Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RBOT vs. The Competition Export to ExcelMetricVicarious SurgicalMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$35.23M$6.51B$5.65B$21.35BDividend YieldN/A1.20%5.68%3.52%P/E Ratio-0.5425.0375.8429.19Price / SalesN/A197.54517.46104.21Price / CashN/A21.7937.5624.47Price / Book0.695.0112.874.52Net Income-$63.22M$178.07M$3.29B$1.00B7 Day Performance-5.94%-1.26%-0.26%-1.35%1 Month Performance-19.16%6.15%3.84%2.04%1 Year Performance0.83%22.81%68.35%13.83% Vicarious Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RBOTVicarious Surgical2.0225 of 5 stars$5.47-8.0%$7.00+28.1%+8.3%$35.23MN/A-0.54210News CoverageHigh Trading VolumeSPAISafe Pro Group3.3263 of 5 stars$7.14+2.7%$10.50+47.1%+126.1%$130.75M$2.17M-8.9211Positive NewsPROFProfound Medical1.8602 of 5 stars$4.30-0.9%$11.00+155.8%-28.4%$130.73M$10.68M-2.95150News CoveragePositive NewsHigh Trading VolumeINOInovio Pharmaceuticals3.8707 of 5 stars$2.49+8.3%$8.80+253.4%-57.5%$122.23M$220K-0.95320News CoverageHYPRHyperfine1.6701 of 5 stars$1.49+2.8%$1.28-13.9%+48.3%$113.94M$12.89M-2.87190PDEXPro-Dex3.0255 of 5 stars$34.34-0.1%$56.00+63.1%+31.4%$112.08M$66.59M12.72140NSPRInspireMD3.425 of 5 stars$2.44-0.4%$4.50+84.4%-12.0%$101.80M$7.07M-3.2550Positive NewsBDMDBaird Medical InvestmentN/A$2.51-4.9%N/AN/A$94.32MN/A0.00N/APositive NewsGap DownOBIOOrchestra BioMed2.9749 of 5 stars$2.45+0.4%$13.50+451.0%-47.5%$94.29M$2.64M-1.344Positive NewsFONRFonar1.1455 of 5 stars$15.20+0.4%N/A-11.9%$93.92M$102.88M12.16480Earnings ReportUpcoming EarningsEDAPEdap Tms2.2846 of 5 stars$2.54+1.6%$8.50+234.6%-16.4%$93.48M$69.18M-4.16230Positive News Related Companies and Tools Related Companies SPAI Alternatives PROF Alternatives INO Alternatives HYPR Alternatives PDEX Alternatives NSPR Alternatives BDMD Alternatives OBIO Alternatives FONR Alternatives EDAP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RBOT) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicarious Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RBOT Stock Alerts